Does USTEKINUMAB-STBA Cause Off label use? 43 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Off label use have been filed in association with USTEKINUMAB-STBA. This represents 23.4% of all adverse event reports for USTEKINUMAB-STBA.
43
Reports of Off label use with USTEKINUMAB-STBA
23.4%
of all USTEKINUMAB-STBA reports
3
Deaths
7
Hospitalizations
How Dangerous Is Off label use From USTEKINUMAB-STBA?
Of the 43 reports, 3 (7.0%) resulted in death, 7 (16.3%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB-STBA. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB-STBA Cause?
Intentional product use issue (46)
Intentional dose omission (21)
Crohn's disease (20)
Death (15)
Haematochezia (13)
Condition aggravated (12)
Diarrhoea (10)
Colitis ulcerative (8)
Psoriasis (8)
Abdominal pain (6)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which USTEKINUMAB-STBA Alternatives Have Lower Off label use Risk?
USTEKINUMAB-STBA vs VADADUSTAT
USTEKINUMAB-STBA vs VALACYCLOVIR
USTEKINUMAB-STBA vs VALBENAZINE
USTEKINUMAB-STBA vs VALBENAZINE DITOSYLATE
USTEKINUMAB-STBA vs VALDECOXIB